CellSignals' Other Investors

CellSignals raised a round of funding on , . Investors include Rev1 Ventures.

CellSignals applies its technology in chiral synthesis to develop lipid mediators pertinent to intracellular signal transduction and cancer biology. Currently CellSignals' product line has grown to mo…

Articles about CellSignals' Other Investors: